Endocrine Cancer Archives - Cancer Therapy Advisor

Genomic analysis of tumors and tests measuring certain biomarkers can be done in-house or sent out. What are the costs and benefits of each approach?

In-House or Centralized Testing? Debating Whether Genomic Sequencing Is Best Conducted at Home

By

Karen Weintraub

May 14, 2019

Genomic analysis of tumors and tests measuring certain biomarkers can be done in-house or sent out. What are the costs and benefits of each approach?

Endocrine Cancer

Once-Weekly Exenatide Treatment Does Not Increase Risk for Medullary Thyroid Carcinoma

By

Amit Akirov, MD

May 14, 2019

Treatment with once-weekly exenatide 2 mg does not increase serum calcitonin concentrations or the risk for medullary thyroid carcinoma.

As understanding of cancer improves, drug development could become accelerated, necessitating a means for determining whether a drug is actually effective.

General Oncology

What Do Surrogate End Points Actually Predict?

By

Jonathan Goodman, MPhil

May 9, 2019

As understanding of cancer improves, drug development could become accelerated, necessitating a means for determining whether a drug is actually effective.

Endocrine Cancer

Cumulative Risk for Thyroid Cancer After Initial Benign Thyroid Biopsy

By

Tyler Rice

May 8, 2019

Patients who initially received negative thyroid biopsy results might face higher cumulative risk of developing thyroid cancer than that projected in previous literature.

Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.

General Oncology

Enhanced Reimbursement Incentives for Generic Cancer Drugs Found Not to Affect Prescribing Patterns

By

Randi Hernandez

May 7, 2019

Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.